American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$355M |
| 2 |
Gilead Sciences
GILD
|
+$211M |
| 3 |
CMA
Comerica
CMA
|
+$192M |
| 4 |
Dow Inc
DOW
|
+$167M |
| 5 |
Zebra Technologies
ZBRA
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$297M |
| 2 |
Boeing
BA
|
+$271M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$270M |
| 4 |
Mondelez International
MDLZ
|
+$226M |
| 5 |
JPMorgan Chase
JPM
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.82% |
| 2 | Healthcare | 15.61% |
| 3 | Technology | 15.09% |
| 4 | Consumer Discretionary | 11.61% |
| 5 | Industrials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Oneok
OKE
$58.4B
| $3.19M | ﹤0.01% |
46,379
+1,336
| +3% | +$90K |
|
|
YELL
927
DELISTED
Yellow Corporation Common Stock
YELL
| $3.18M | ﹤0.01% |
790,082
-85,553
| -10% | -$495K |
|
928
Ironwood Pharmaceuticals
IRWD
$674M
| $3.17M | ﹤0.01% |
289,701
+48,720
| +20% | +$546K |
|
|
VGR
929
DELISTED
Vector Group Ltd.
VGR
| $3.17M | ﹤0.01% |
481,004
-7,934
| -2% | -$53K |
|
930
Western Union
WU
$2.34B
| $3.14M | ﹤0.01% |
157,877
-46,165
| -23% | -$900K |
|
931
iShares MSCI Taiwan ETF
EWT
$11.6B
| $3.13M | ﹤0.01% |
89,493
-6,966
| -7% | -$241K |
|
932
OneMain Financial
OMF
$7.51B
| $3.12M | ﹤0.01% |
92,201
+72,477
| +367% | +$2.37M |
|
933
OraSure Technologies
OSUR
$277M
| $3.11M | ﹤0.01% |
335,243
+1,243
| +0.4% | +$11.4K |
|
|
VRE
934
DELISTED
Veris Residential
VRE
| $3.11M | ﹤0.01% |
+133,559
| New | +$3.06M |
|
935
Central Garden & Pet Co Class A
CENTA
$2.41B
| $3.1M | ﹤0.01% |
157,356
-36,564
| -19% | -$735K |
|
|
PVLA
936
Palvella Therapeutics
PVLA
$2.26B
| $3.1M | ﹤0.01% |
8,246
-1,280
| -13% | -$382K |
|
|
AVID
937
DELISTED
Avid Technology Inc
AVID
| $3.09M | ﹤0.01% |
+339,002
| New | +$2.77M |
|
938
Supernus Pharmaceuticals
SUPN
$2.74B
| $3.08M | ﹤0.01% |
93,189
+4,231
| +5% | +$145K |
|
939
Toro Company
TTC
$9.21B
| $3.08M | ﹤0.01% |
46,056
-3,108
| -6% | -$218K |
|
|
DRNA
940
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $3.06M | ﹤0.01% |
+194,530
| New | +$2.65M |
|
941
Stoke Therapeutics
STOK
$2.02B
| $3.06M | ﹤0.01% |
+104,883
| New | +$2.82M |
|
|
FLOW
942
DELISTED
SPX FLOW, Inc.
FLOW
| $3.05M | ﹤0.01% |
72,773
+4,284
| +6% | +$158K |
|
943
Harmony Gold Mining
HMY
$12B
| $3.02M | ﹤0.01% |
1,328,000
| – | – |
|
944
Regenxbio
RGNX
$704M
| $3.01M | ﹤0.01% |
58,649
-31,491
| -35% | -$1.57M |
|
|
EGRX
945
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.01M | ﹤0.01% |
+54,093
| New | +$2.82M |
|
|
RETA
946
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $3.01M | ﹤0.01% |
31,909
-87
| -0.3% | -$7.51K |
|
|
RST
947
DELISTED
ROSETTA STONE INC
RST
| $3.01M | ﹤0.01% |
+131,578
| New | +$3.17M |
|
948
Rollins
ROL
$17.4B
| $2.99M | ﹤0.01% |
+124,971
| New | +$3.22M |
|
949
Elastic
ESTC
$8.94B
| $2.98M | ﹤0.01% |
39,863
-115
| -0.3% | -$9.39K |
|
|
ANSS
950
DELISTED
Ansys
ANSS
| $2.97M | ﹤0.01% |
14,508
+8,576
| +145% | +$1.63M |
|
Similar funds
American Century Companies's Q2 2019 Portfolio in Review
As of Q2 2019, American Century Companies held 1,423 positions worth $100B, up 1.8% from $98.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
American Century Companies's Q2 2019 filing shows 209 new, 531 increased, 497 reduced and 163 closed positions. Its largest new stake was Dow Inc: 3,155,090 shares worth $156M. The largest sale was Apple, an estimated $297M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
- American Century Companies's largest Q2 2019 buy was Dow Inc: 3,155,090 shares worth $156M.
- American Century Companies added most to iShares Russell 1000 Value ETF in Q2 2019, an estimated $355M increase.
- American Century Companies's biggest Q2 2019 reduction was Apple, cutting an estimated $297M.
- American Century Companies fully exited WABCO HOLDINGS INC. in Q2 2019, selling an estimated $149M.
- American Century Companies's ten largest holdings make up 18% of its $100B portfolio in Q2 2019.
- American Century Companies opened 209 new positions and closed 163 in Q2 2019.
- American Century Companies's portfolio value rose 1.8% quarter-over-quarter to $100B.
Based on American Century Companies's 13F filing for Q2 2019, filed 14 Aug 2019.